Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...

BTIG analyst Andre Madrid raised the firm’s price target on FTAI Aviation (FTAI) to $190 from $180 and keeps a Buy rating on the shares. The ...

BTIG raised the firm’s price target on Insulet (PODD) to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology ...

BTIG raised the firm’s price target on Verastem (VSTM) to $20 from $13 and keeps a Buy rating on the shares after the company announced the FDA ...

BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating ...

Analyst initiates coverage on cloud-based auto services provider SunCar Technology (SDA) with Buy rating, projecting 25% annualized growth.

According to a BTIG strategist, the rally in the index was rejected from the previous support trendline and even though there are still four days left for the Santa Claus rally to deliver gains, there ...

Fintel reports that on December 23, 2024, BTIG downgraded their outlook for Innovative Industrial Properties, Inc. - ...

BTIG said it would be cautious on Apple's ( NASDAQ: AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the market can continue to make upside progress into the year-end and see a new ...

Stock analysts at BTIG Research started coverage on shares of Cartesian Therapeutics (NASDAQ:RNAC – Get Free Report) in a ...